1. Home
  2. WVE vs FBRT Comparison

WVE vs FBRT Comparison

Compare WVE & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • FBRT
  • Stock Information
  • Founded
  • WVE 2012
  • FBRT 2012
  • Country
  • WVE Singapore
  • FBRT United States
  • Employees
  • WVE N/A
  • FBRT N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • FBRT Real Estate Investment Trusts
  • Sector
  • WVE Health Care
  • FBRT Real Estate
  • Exchange
  • WVE Nasdaq
  • FBRT Nasdaq
  • Market Cap
  • WVE 915.6M
  • FBRT 933.1M
  • IPO Year
  • WVE 2015
  • FBRT 1985
  • Fundamental
  • Price
  • WVE $6.50
  • FBRT $11.03
  • Analyst Decision
  • WVE Strong Buy
  • FBRT Strong Buy
  • Analyst Count
  • WVE 13
  • FBRT 6
  • Target Price
  • WVE $20.15
  • FBRT $15.25
  • AVG Volume (30 Days)
  • WVE 1.0M
  • FBRT 706.4K
  • Earning Date
  • WVE 08-07-2025
  • FBRT 07-30-2025
  • Dividend Yield
  • WVE N/A
  • FBRT 13.28%
  • EPS Growth
  • WVE N/A
  • FBRT N/A
  • EPS
  • WVE N/A
  • FBRT 0.67
  • Revenue
  • WVE $104,939,000.00
  • FBRT $175,693,000.00
  • Revenue This Year
  • WVE N/A
  • FBRT $29.44
  • Revenue Next Year
  • WVE $1.94
  • FBRT $2.22
  • P/E Ratio
  • WVE N/A
  • FBRT $15.96
  • Revenue Growth
  • WVE N/A
  • FBRT N/A
  • 52 Week Low
  • WVE $4.87
  • FBRT $10.50
  • 52 Week High
  • WVE $16.74
  • FBRT $14.12
  • Technical
  • Relative Strength Index (RSI)
  • WVE 45.10
  • FBRT 51.52
  • Support Level
  • WVE $6.67
  • FBRT $10.81
  • Resistance Level
  • WVE $7.10
  • FBRT $11.23
  • Average True Range (ATR)
  • WVE 0.38
  • FBRT 0.18
  • MACD
  • WVE -0.02
  • FBRT 0.03
  • Stochastic Oscillator
  • WVE 7.77
  • FBRT 71.55

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About FBRT Franklin BSP Realty Trust Inc.

Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.

Share on Social Networks: